|
Market Closed -
Nasdaq Helsinki
12:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 79.45 EUR | +0.44% |
|
+0.44% | +24.82% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 76.67 | -3.08% | 6 | ||||||
| 1,315.04 | +13.69% | 29 | ||||||
| 272.5 | +2.5% | 22 | ||||||
| 276.59 | +7.86% | 29 | ||||||
| 370.31 | +4.96% | 18 | ||||||
| 154.32 | +1.22% | 21 | ||||||
| 212.66 | +31.03% | 22 | ||||||
| 388.48 | -9.63% | 29 | ||||||
| 309.73 | +5.93% | 23 | ||||||
| 157.41 | +7.56% | 27 | ||||||
| 28.61 | +0.51% | 26 | ||||||
| 563.12 | +3.42% | 25 | ||||||
| 66.21 | -0.9% | 24 | ||||||
| 94.28 | +22.74% | 23 | ||||||
| 21.69 | +17.01% | 20 | ||||||
| 9,350 | +35.25% | 15 | ||||||
| 6,547.06 | +13.57% | 16 | ||||||
| 57.39 | +17.02% | 18 | ||||||
| 71.74 | +55.71% | 17 | ||||||
| 4.214 | +14.45% | 17 | ||||||
| Average | 1,016.9 | +12.04% | 21 | ||||||
| Weighted average by Cap. | 705.68 | +9.08% | 24 |
- Stock Market
- Stocks
- ORNBV Stock
- Sector Orion Oyj
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
